{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:37:08Z","timestamp":1768916228508,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8950","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1016\/s0140-6736(95)90520-0","type":"journal-article","created":{"date-parts":[[2003,9,16]],"date-time":"2003-09-16T22:31:56Z","timestamp":1063751516000},"page":"610-614","source":"Crossref","is-referenced-by-count":121,"title":["Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation"],"prefix":"10.1016","volume":"345","author":[{"given":"A.A.M.J.","family":"Hollander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.C.M.","family":"van Saase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"van Es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"van derWoude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"van Bockel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.C.M.","family":"van Saase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.M.","family":"Kootte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.T.","family":"van Dorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(95)90520-0_BIB1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM196306132682401","article-title":"Prolonged survival of human-kidney homografts by immunosuppressive drug therapy","volume":"268","author":"Murray","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(83)90978-9","article-title":"Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial","volume":"ii","author":"European Multicentre Trial Group","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM198310063091401","article-title":"A randomized clinical trial of cyclosporine in cadaveric renal transplantation","volume":"309","author":"The Canadian Multicentre Transplant Study Group","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB4","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors","volume":"ii","author":"Calne","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000183550","article-title":"Chronic irreversible nephrotoxicity from cyclosporin A","volume":"41","author":"Rao","year":"1985","journal-title":"Nephron"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00007890-198811000-00010","article-title":"Controlled cyclosporine conversion at three months after renal transplantation","volume":"46","author":"Kootte","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/oxfordjournals.ndt.a091725","article-title":"High- and low-dose regimens of cyclosporine in renal transplantation: immunosuppressive efficacy and side effects","volume":"3","author":"Kootte","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198806093182304","article-title":"Comparison of three immunosuppressive regimens in cadaver renal transplantation: long term cyclosporine, short term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine","volume":"318","author":"Hall","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(87)90232-7","article-title":"Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients","volume":"i","author":"Hoitsma","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jama.1993.03500030093040","article-title":"Elective cyclosporine withdrawal after renal transplantation: a meta-analysis","volume":"269","author":"Kasiske","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007890-198503000-00013","article-title":"Improved patient and graft survival after treatment of acute rejections of cadaveric renal allografts with rabbit antithymocyte globulin","volume":"39","author":"Hoitsma","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00007890-198412000-00024","article-title":"Conversion from cyclosporine to azathioprine in renal allograft recipients","volume":"38","author":"Rocher","year":"1984","journal-title":"Transplantation"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB13","first-page":"2000","article-title":"Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients","volume":"19","author":"Tegzess","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB14","first-page":"2677","article-title":"Management of cyclosporine nephrotoxicity by conversion to azathioprine or by reduction of cyclosporine dose and addition of azathioprine","volume":"17","author":"Canafax","year":"1985","journal-title":"Transplant Proc"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0140-6736(87)90233-9","article-title":"Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation","volume":"i","author":"Morris","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0272-6386(12)80355-6","article-title":"The adverse impact of cyclosporine on serum lipids in renal transplant recipients","volume":"17","author":"Kasiske","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/106002808802200601","article-title":"Systemic hypertension associated with cyclosporin: a review","volume":"22","author":"Weidle","year":"1988","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB18","first-page":"192","article-title":"Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine","volume":"18","author":"Canafax","year":"1986","journal-title":"Transplant Proc"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB19","first-page":"2342","article-title":"Collaborative transplant study\u201410 year report","volume":"24","author":"Opelz","year":"1992","journal-title":"Transplant Proc"},{"key":"10.1016\/S0140-6736(95)90520-0_BIB20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198908033210504","article-title":"Cyclosporine-induced hyperuricemia and gout","volume":"321","author":"Lin","year":"1989","journal-title":"N Engl J Med"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673695905200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673695905200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T16:27:31Z","timestamp":1555345651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673695905200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":20,"journal-issue":{"issue":"8950","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["S0140673695905200"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(95)90520-0","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}